Correlation Between Biomarin Pharmaceutical and Mirati Ther

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceutical and Mirati Ther at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceutical and Mirati Ther into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceutical and Mirati Ther, you can compare the effects of market volatilities on Biomarin Pharmaceutical and Mirati Ther and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceutical with a short position of Mirati Ther. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceutical and Mirati Ther.

Diversification Opportunities for Biomarin Pharmaceutical and Mirati Ther

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Biomarin and Mirati is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and Mirati Ther in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mirati Ther and Biomarin Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceutical are associated (or correlated) with Mirati Ther. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mirati Ther has no effect on the direction of Biomarin Pharmaceutical i.e., Biomarin Pharmaceutical and Mirati Ther go up and down completely randomly.

Pair Corralation between Biomarin Pharmaceutical and Mirati Ther

If you would invest  6,913  in Biomarin Pharmaceutical on July 23, 2024 and sell it today you would earn a total of  98.00  from holding Biomarin Pharmaceutical or generate 1.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy4.76%
ValuesDaily Returns

Biomarin Pharmaceutical  vs.  Mirati Ther

 Performance 
       Timeline  
Biomarin Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biomarin Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in November 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Mirati Ther 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mirati Ther has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Mirati Ther is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Biomarin Pharmaceutical and Mirati Ther Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biomarin Pharmaceutical and Mirati Ther

The main advantage of trading using opposite Biomarin Pharmaceutical and Mirati Ther positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceutical position performs unexpectedly, Mirati Ther can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mirati Ther will offset losses from the drop in Mirati Ther's long position.
The idea behind Biomarin Pharmaceutical and Mirati Ther pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years